ICSR ValidationPharmacovigilance Case ProcessingValid ICSRsICSR Intake WorkflowSafety Case Validation

ICSR Validation Case Study: Recovering Valid Pharmacovigilance Cases

See how PVCON helped a pharmaceutical company improve ICSR intake, recover valid cases, strengthen validation controls and improve reporting timelines.

PVCON Team4 min read
Client
Pharmaceutical company
Focus
ICSR intake review, validation workflow, QC controls and PV process improvement
Duration
12 weeks
ICSR Validation Case Study: Recovering Valid Pharmacovigilance Cases

Results

of rejected cases recovered
12%of rejected cases recovered
fewer validation errors
60%fewer validation errors
on-time reporting
88% → 99%on-time reporting
engagement duration
12 weeksengagement duration

Recovering Valid Cases Before They Were Lost

How PVCON helped a pharmaceutical company strengthen ICSR intake processes, recover valid safety reports and improve case-processing accuracy.

Valid Safety Cases Were Being Missed During Intake

A pharmaceutical company managing global safety information identified inconsistencies within its Individual Case Safety Report (ICSR) intake process.

Reports received from different sources were being reviewed against minimum criteria requirements, but variations in interpretation were leading to valid cases being rejected or incorrectly classified during initial assessment.

The challenge was not a lack of reporting volume.

The concern was whether every potentially reportable case was being identified, validated and progressed within the required timelines.

The company needed to strengthen its pharmacovigilance processes by improving intake consistency, reinforcing validation criteria and establishing stronger quality controls around case assessment.

Rebuilding the Intake Process Around Consistent Case Assessment

PVCON reviewed the company's ICSR intake workflow to identify where interpretation differences were affecting case validation.

The engagement focused on reassessing previously rejected cases, reviewing the application of minimum criteria, strengthening procedural guidance and improving quality oversight.

The team supported improvements across:

  • ICSR intake workflow review
  • Case validation assessment
  • Procedure updates
  • Quality control checkpoints
  • Team retraining on case assessment principles

The updated approach was designed to help the organisation make consistent decisions while ensuring that valid safety information progressed through the appropriate pharmacovigilance pathway.

The process improvements were aligned with the principles of a controlled pharmacovigilance quality system, where decisions need to be traceable, documented and supported by defined procedures.

What Needed to Be Strengthened

PV Process AreaChallenge IdentifiedPVCON SupportOutcome
ICSR IntakeValid cases were being rejected during initial reviewReviewed intake workflow and reassessed rejected cases12% of rejected cases recovered
Case ValidationInconsistent interpretation of minimum criteriaUpdated validation approach and proceduresValidation errors reduced by 60%
Quality ControlsLimited checkpoints before case rejectionAdded QC reviews and oversight mechanismsImproved consistency in case decisions
Team CapabilityDifferent approaches across reviewersConducted targeted team trainingBetter alignment across case-processing activities
Reporting TimelinesDelays caused by rework and correctionsImproved workflow efficiencyOn-time reporting increased from 88% to 99%

Before and after ICSR intake: multiple safety reports reaching inconsistent accept, reject or more-information decisions, replaced by a structured flow from incoming safety report through data validation and review to a final accept, reject or more-information decision

Turning Missed Opportunities Into a More Reliable Safety Process

Through the workflow review and corrective actions, the organisation recovered 12% of previously rejected cases that required further assessment.

The updated validation approach improved consistency across reviewers, reducing validation errors by 60%.

As a result of improved intake controls and reduced rework, on-time reporting performance increased from 88% to 99%.

The outcome was not only improved case processing speed. The organisation gained a more structured approach to identifying, assessing and managing incoming safety information.

Strengthening the First Step of the PV Process

ICSR quality begins before case processing starts.

When intake decisions are inconsistent, the impact can extend across reporting timelines, signal evaluation, aggregate reporting and inspection readiness.

For this organisation, strengthening the intake process created a more reliable foundation for downstream pharmacovigilance activities.

PVCON supports organisations with pharmacovigilance consulting, including process improvement, quality system strengthening, PV audits and inspection readiness support.

Need to improve your ICSR validation process? Explore PVCON's pharmacovigilance consulting support or contact PVCON to discuss strengthening your safety operations.